Atlas FDA

Medtronic SynchroMed EL Programmable Pump, Model 8627-18. 18 mL Reservoir. The contents [STERILE] of the inner package h

FDA device recall Z-0589-2009 · posted 2009-01-26 · Terminated

Recall details

Recalling firm
Medtronic Neuromodulation
Reason for recall
Medtronic issued a letter to healthcare professionals providing important safety information regarding MRI (magnetic resonance imaging) effects on SynchroMed EL and SynchroMed II implantable infusion pumps. As stated in product labeling, the magnetic field of an MRI will temporarily stop the rotor of the pump motor and suspend drug infusion for the duration of MRI exposure for all SynchroMed pump
Action taken
An Urgent Medical Device Correction, Important Information on Potential MRI Effects letter, dated August 2008, was sent to health care professionals beginning August 25, 2008. The letter described the issue, provided patient management recommendations and included enclosures: Roller Study Procedure to confirm pump function, Post MRI Pump Interrogation Guidelines and New Information Regarding Potential MRI Effects.
Root cause
Labeling Change Control
Status
Terminated
Product code
LKK
Quantity affected
Approx 76,253 of all devices.
Distribution
Worldwide Distribution --- USA including Washington D.C., and Puerto Rico, and countries of Algeria, Aruba, Austria, Belarus, Belgium, Croatia, Cyprus Czech Republic, Denmark, Egypt, Finland, France,
Date initiated
2008-08-25
Date posted
2009-01-26
Date terminated
2012-05-17
Location
Minneapolis, MN

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.